CORRECTING and REPLACING -- Tetraphase Pharmaceuticals to Participate at Upcoming Investor Conference
August 27 2018 - 12:00PM
In a release issued earlier today by Tetraphase Pharmaceuticals,
Inc. (NASDAQ:TTPH) please note that the upcoming investor
conference details have been updated. The corrected release
follows:
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a
biopharmaceutical company focused on developing and commercializing
novel antibiotics to treat life-threatening multidrug-resistant
(MDR) infections, today announced that company management will give
a corporate presentation at the H. C. Wainwright 20th Annual Global
Investment Conference on Wednesday, September 5, 2018 at 12:30 p.m.
Eastern Time at the St. Regis Hotel in New York City.
A live audio webcast of the H. C. Wainwright
presentation will be available on the company’s website at
http://ir.tphase.com/events.cfm. The archived presentation will be
available for 30 days.
About Tetraphase Pharmaceuticals,
Inc.Tetraphase is a biopharmaceutical company using its
proprietary chemistry technology to create novel antibiotics for
serious and life-threatening bacterial infections, including those
caused by many of the multidrug-resistant bacteria highlighted as
urgent public health threats by the World Health Organization and
Centers for Disease Control and Prevention. The Company has created
more than 3,000 novel tetracycline compounds using its proprietary
technology platform. Tetraphase's pipeline includes three
antibiotic clinical candidates: eravacycline, TP-271 and TP-6076.
Eravacycline has completed phase 3 clinical testing and is under
review for potential approval in cIAI by the U.S. Food and Drug
Administration, with a Prescription Drug User Fee Act date of
August 28, 2018 and has received a positive opinion from the
Committee for Medicinal Products for Human Use of the European
Medicines Agency. TP-271 and TP-6076 are in phase 1 clinical
trials. Please visit www.tphase.com for more company
information.
Media and Investor Contact:Tetraphase
PharmaceuticalsJennifer Viera617-600-7040jviera@tphase.com
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jul 2024 to Jul 2024
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jul 2023 to Jul 2024